Plant Health Care secures Arysta commercialisation deal - UPDATE

Plant Health Care (PHC), the developer of naturally derived agricultural products, has secured a long-awaited commercial contract with agrichemicals giant Arysta LifeScience Corporation.

Plant Health Care (PHC), the developer of naturally derived agricultural products, has secured a long-awaited commercial contract with agrichemicals giant Arysta LifeScience Corporation.

Following on from a research agreement between the two companies, the pair have agreed to develop and commercialise PHC's Harpin '' crop improvement technology in several crops and markets, in combination with a number of private equity-owned Arysta's leaf treatment products.

The companies confirmed that, following official registration, the combined product would be ready for first sales in the USA in time for the 2014 spraying season.

PHC and Arysta's research has demonstrated that use of Harpin in combination with plant protection fungicides called triazoles can make a significant contribution to the management of the increased disease resistance being seen in the popular range of strobilurin fungicides.

Wayne Hewett, President and Chief Executive Officer (CEO) of Arysta LifeScience, said the technology had been "validated in the United States corn and soybean market and Arysta LifeScience is focused on launching new products in the United States market in 2014 as well as developing the concept in a number of crops and countries."

Paul Schmidt, CEO of PHC, added that the deal marked "a significant step forward for Plant Health Care" but did not disclose the commercial terms of the deal.

In March, broker Nomura Code noted that PHC had hoped "to soon conclude the foliar Harpin deal that was mentioned in the January trading update. We expect this deal to be significant with the potential for a circa $1.0m upfront payment which would demonstrate significant value seen in the product by another well known agrichemicals company."

On the announcement of the deal, Nomura's John-Marc Bunce added that "we also see the speed of progress in this relationship to commercial launch as a positive indicator of the buy-in from this global agrichemicals company".

Shares in PHC remained unmoved at 87.50p at 11.09 on the day of the announcement.

OH

Recommended

The top funds to invest in
Funds

The top funds to invest in

As market volatility and recessionary fears continue, here are the most popular funds, stocks and trusts investors are putting their money into
2 Mar 2023
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves takes a look at the companies with the highest dividend yields in the UK’s blue-chip index
27 Feb 2023
The outlook for Shell shares is mixed, despite bumper profits
Energy stocks

The outlook for Shell shares is mixed, despite bumper profits

With profits surging, it looks as if Shell is on a roll, but the company’s growth from here is hard to see as Rupert Hargreaves explains.
6 Feb 2023
The top ten dividend stocks in the FTSE 250
Share tips

The top ten dividend stocks in the FTSE 250

The average FTSE 250 dividend yield is around 4%, but many stocks yield much more. Rupert Hargreaves picks the best FTSE 250 stocks for income investo…
17 Jan 2023

Most Popular

Bank of England hikes key interest rate to 4.25%
UK Economy

Bank of England hikes key interest rate to 4.25%

The Bank of England raised rates by 0.25% following a surprise jump in inflation.
23 Mar 2023
Will energy prices go down in 2023?
Personal finance

Will energy prices go down in 2023?

Ofgem’s price cap is now predicted to fall below £2,000, based on average typical use, from July, for the first time since 2022. We have all the detai…
21 Mar 2023
When will interest rates go up?
UK Economy

When will interest rates go up?

The Bank of England raised rates to 4.25%, its 11th consecutive increase. Does the base rate have further to go?
23 Mar 2023